Zolpidem in Parkinson's disease [7]

Lancet

Volumn 349, Issue 9060, 1997, Pages 1222-1223

  Daniele, A ^a   Albanese, A ^a   Gainotti, G ^a   Gregori, B ^a   Bartolomeo, P ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; ZOLPIDEM;

ADULT; AGED; BASAL GANGLION; BINDING SITE; CASE REPORT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INSOMNIA; LETTER; NEUROTRANSMISSION; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030936557     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62416-6     Document Type: Article

References (5)

1. J Jankovic CD Marsden Therapeutic strategies in Parkinson's disease J Jankovic E Tolosa Parkinson's disease and movement disorders 1988 Urban and Schwarzenberg Baltimore and Munich 95 119
2. SZ Langer S Arbilla B Scatton R Niddam A Dubois Receptors involved in the mechanisms of action of zolpidem JP Sauvanet SZ Langer PL Morselli Imidazopyridines in sleep disorders 1988 Raven Press New York 55 70
3. WRG Gibb AJ Lees The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease J Neurol Neurosurg Psychiatry 51 1988 745 752
4. J Schwarz K Tatsch G Arnold 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism Neurology 43 suppl 6 1993 S17 S20
5. ST Grafton C Waters J Sutton MF Lew W Couldwell Pallidotomy increases activity of motor association cortex in Parkinson's disease: a positron emission tomographic study Ann Neurol 37 1995 776 783